Progyny, Inc. Operating Cash Flow
Progyny, Inc. (PGNY) reported Operating Cash Flow of $96.37 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-07
- Progyny, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $50.42M, a 9.16% decline year-over-year.
- Progyny, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $45.95M, a 7.75% decline year-over-year.
- Progyny, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $54.20M, a 3.91% increase year-over-year.
- Progyny, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $50.67M, a 13.83% increase year-over-year.
- Progyny, Inc. net cash provided by (used in) operating activities for fiscal 2025 was $210.19M, a 17.36% increase from fiscal 2024.
- Progyny, Inc. net cash provided by (used in) operating activities for fiscal 2024 was $179.10M, a 5.14% decline from fiscal 2023.
- Progyny, Inc. net cash provided by (used in) operating activities for fiscal 2023 was $188.81M, a 134.86% increase from fiscal 2022.
- Progyny, Inc. net cash provided by (used in) operating activities for fiscal 2022 was $80.39M, a 208.77% increase from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $50.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $96.37M 10-Q · filed 2026-08-07 | $150.58M derived: sum of 3 quarters · filed 2026-08-07 | $201.25M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $45.95M 10-Q · filed 2026-05-08 | $100.15M derived: sum of 2 quarters · filed 2026-05-08 | $150.82M derived: sum of 3 quarters · filed 2026-05-08 | $206.33M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $54.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $104.87M derived: sum of 2 quarters · filed 2026-02-27 | $160.38M derived: sum of 3 quarters · filed 2026-08-07 | $210.19M 10-K · filed 2026-02-27 |
| 2025-09-30 | $50.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $106.18M derived: sum of 2 quarters · filed 2026-08-07 | $155.99M 10-Q · filed 2025-11-07 | $208.15M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $55.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $105.32M 10-Q · filed 2026-08-07 | $157.48M derived: sum of 3 quarters · filed 2026-08-07 | $202.00M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $49.81M 10-Q · filed 2026-05-08 | $101.97M derived: sum of 2 quarters · filed 2026-05-08 | $146.49M derived: sum of 3 quarters · filed 2026-05-08 | $203.18M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $52.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $96.68M derived: sum of 2 quarters · filed 2026-02-27 | $153.37M derived: sum of 3 quarters · filed 2026-02-27 | $179.10M 10-K · filed 2026-02-27 |
| 2024-09-30 | $44.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $101.21M derived: sum of 2 quarters · filed 2025-11-07 | $126.94M 10-Q · filed 2025-11-07 | $164.60M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $56.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $82.43M 10-Q · filed 2025-08-08 | $120.08M derived: sum of 3 quarters · filed 2026-02-27 | $174.27M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $25.73M 10-Q · filed 2025-05-09 | $63.39M derived: sum of 2 quarters · filed 2026-02-27 | $117.57M derived: sum of 3 quarters · filed 2026-02-27 | $193.59M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $37.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $91.84M derived: sum of 2 quarters · filed 2026-02-27 | $167.85M derived: sum of 3 quarters · filed 2026-02-27 | $188.81M 10-K · filed 2026-02-27 |
| 2023-09-30 | $54.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $130.19M derived: sum of 2 quarters · filed 2024-11-12 | $151.16M 10-Q · filed 2024-11-12 | $202.67M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $76.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $96.97M 10-Q · filed 2024-08-07 | $148.49M derived: sum of 3 quarters · filed 2025-03-03 | $169.38M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $20.96M 10-Q · filed 2024-05-10 | $72.48M derived: sum of 2 quarters · filed 2025-03-03 | $93.37M derived: sum of 3 quarters · filed 2025-03-03 | $112.62M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | $51.52M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $72.41M derived: sum of 2 quarters · filed 2025-03-03 | $91.66M derived: sum of 3 quarters · filed 2025-03-03 | $80.39M 10-K · filed 2025-03-03 |
| 2022-09-30 | $20.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $40.14M derived: sum of 2 quarters · filed 2023-11-08 | $28.88M 10-Q · filed 2023-11-08 | $37.69M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $19.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $7.98M 10-Q · filed 2023-08-04 | $16.80M derived: sum of 3 quarters · filed 2024-02-29 | $40.96M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | -$11.26M 10-Q · filed 2023-05-09 | -$2.45M derived: sum of 2 quarters · filed 2024-02-29 | $21.72M derived: sum of 3 quarters · filed 2024-02-29 | $14.24M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $8.81M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $32.98M derived: sum of 2 quarters · filed 2024-02-29 | $25.50M derived: sum of 3 quarters · filed 2024-02-29 | $26.04M 10-K · filed 2024-02-29 |
| 2021-09-30 | $24.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $16.69M derived: sum of 2 quarters · filed 2022-11-04 | $17.22M 10-Q · filed 2022-11-04 | $23.76M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | -$7.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | -$6.94M 10-Q · filed 2022-08-05 | -$404.00K derived: sum of 3 quarters · filed 2023-03-01 | $14.93M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $532.00K 10-Q · filed 2022-05-06 | $7.07M derived: sum of 2 quarters · filed 2023-03-01 | $22.40M derived: sum of 3 quarters · filed 2023-03-01 | $24.59M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $6.54M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $21.87M derived: sum of 2 quarters · filed 2023-03-01 | $24.06M derived: sum of 3 quarters · filed 2023-03-01 | $36.20M 10-K · filed 2023-03-01 |
| 2020-09-30 | $15.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $17.53M derived: sum of 2 quarters · filed 2021-11-08 | $29.67M 10-Q · filed 2021-11-08 | $24.18M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $2.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $14.34M 10-Q · filed 2021-08-06 | $8.85M derived: sum of 3 quarters · filed 2022-03-01 | $14.73M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $12.14M 10-Q · filed 2021-05-07 | $6.65M derived: sum of 2 quarters · filed 2022-03-01 | $12.53M derived: sum of 3 quarters · filed 2022-03-01 | $16.78M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | -$5.49M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $390.00K derived: sum of 2 quarters · filed 2022-03-01 | $4.64M derived: sum of 3 quarters · filed 2022-03-01 | -$1.53M 10-K · filed 2022-03-01 |
| 2019-09-30 | $5.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $10.13M derived: sum of 2 quarters · filed 2020-11-06 | $3.96M 10-Q · filed 2020-11-06 | $8.05M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $4.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | -$1.92M 10-Q · filed 2020-08-07 | $2.17M derived: sum of 3 quarters · filed 2021-03-01 | |
| 2019-03-31 | -$6.17M 10-Q · filed 2020-05-14 | -$2.08M derived: sum of 2 quarters · filed 2021-03-01 | ||
| 2018-12-31 | $4.10M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $2.27M 10-K · filed 2021-03-01 | ||
| 2018-09-30 | -$1.82M 10-Q · filed 2019-12-06 | |||
| 2017-12-31 | -$9.47M 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |